Bill Text: NH SB567 | 2024 | Regular Session | Amended
Bill Title: Directing the commissioner of the department of health and human services to compile a report on the availability of mifepristone and misoprostol.
Spectrum: Partisan Bill (Democrat 14-0)
Status: (Engrossed) 2024-05-08 - Executive Session: 05/14/2024 01:00 pm Legislative Office Building 210-211 [SB567 Detail]
Download: New_Hampshire-2024-SB567-Amended.html
SB 567-FN - AS AMENDED BY THE SENATE
02/15/2024 0714s
2024 SESSION
24-3103
05/08
SENATE BILL 567-FN
SPONSORS: Sen. Whitley, Dist 15; Sen. D'Allesandro, Dist 20; Sen. Rosenwald, Dist 13; Sen. Soucy, Dist 18; Sen. Perkins Kwoka, Dist 21; Sen. Altschiller, Dist 24; Sen. Watters, Dist 4; Sen. Fenton, Dist 10; Sen. Chandley, Dist 11; Sen. Prentiss, Dist 5; Rep. Brennan, Merr. 9; Rep. Hakken-Phillips, Graf. 12; Rep. M. Murray, Hills. 37; Rep. Toll, Ches. 15
COMMITTEE: Judiciary
-----------------------------------------------------------------
AMENDED ANALYSIS
This bill directs the commissioner of the department of health and human services to compile a report on the availability of mifepristone and misoprostol.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
02/15/2024 0714s 24-3103
05/08
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Twenty Four
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 Department of Health and Human Services; Report; Availability of Mifepristone and Misoprostol.
I. The commissioner of the department health and human services or designee shall submit a report to the senate president, the speaker of the house of representatives, the house clerk, and the senate clerk by November 1, 2024:
(a) Identifying potential actions to protect and expand access to mifepristone and misoprostol;
(b) Identifying ways to increase outreach and education about access to mifepristone and misoprostol; and
(c) Identifying barriers to protecting or expanding access to mifepristone and misoprostol.
II. Nothing in this section shall diminish any existing authority of the department, or require the department to conduct any activity in violation of state or federal law.
III. No general funds shall be appropriated for the purposes of completing this report. The department shall seek and apply for any appropriate grants and federal funds available to complete this report.
2 Effective Date. This act shall take effect upon its passage.
24-3103
Revised 12/26/23
SB 567-FN- FISCAL NOTE
AS INTRODUCED
AN ACT relative to protecting and expanding access to abortion medications.
FISCAL IMPACT: [ X ] State [ ] County [ ] Local [ ] None
|
| |||||
Estimated State Impact - Increase / (Decrease) | ||||||
| FY 2024 | FY 2025 | FY 2026 | FY 2027 | ||
Revenue | $0 | $0 | $0 | $0 | ||
Revenue Fund(s) | None | |||||
Expenditures | $0 | $109,000 | $106,000 | $109,000 | ||
Funding Source(s) | General Fund | |||||
Appropriations | $0 | $0 | $0 | $0 | ||
Funding Source(s) | None | |||||
• Does this bill provide sufficient funding to cover estimated expenditures? [X] No • Does this bill authorize new positions to implement this bill? [X] No | ||||||
METHODOLOGY:
This bill requires the Department of Health and Human Services to protect and expand access to medications for reproductive health, including medication abortion. The Department anticipates that it will need to hire a new staff position (Program Specialist IV, labor grade 25) to oversee the work required by the bill, including researching, collecting information, and publishing the required report. The Department is unable to estimate the additional costs associated with protecting and increasing access to medication abortion, but it assumes that the new staff position will also be responsible for those activities. The Department is also unable to determine whether there will be costs in FY26 and FY27, as the bill is not specific with respect to the Department’s responsibilities to “protect and expand access." Assuming the position will continue through at least FY27, salary, benefits, and related expenses will cost $109,000 in FY25, $106,000 in FY26, and $109,000 in FY27.
The Department notes that current federal and general funds appropriated to for family planning and reproductive health are prohibited from being used for abortion-related activities. Current Department resources may be used only to identify ways to increase outreach and education about contraception and access to preventative health care services.
AGENCIES CONTACTED:
Department of Health and Human Services
